AzTrials
AzTrials

AnxietyNCT06804967

Effects of Virtual Reality Relaxation on the Anxiety Levels

A study testing virtual reality relaxation headset in people with Anxiety, run by Indiana University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to determine the effects of virtual reality relaxation on dental anxiety levels of adolescents and adults during an orthodontic bonding procedure. Read more about this study

Who is it for?
Ages 13 years and olderHealthy volunteers can take part
Conditions the study is for
Anxiety
What is being tested?
virtual reality relaxation headset
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
1 siteUnited States
Study dates
21 Jan 2025to 4 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Scheduled for fixed orthodontic treatment at IUSD Graduate Orthodontic Clinic
  • Comprehensive treatment case
  • Maxillary or mandibular arch bonding
  • Patients > 13 years of age
  • Must be able to read written English and comprehend spoken English

Who cannot join

  • Re-treatment cases
  • Diagnosed and/or reported clinical general anxiety disorder
  • Currently taking pharmacologic anxiolytics
  • Light hypersensitivity
  • Self-reported history of seizures, concussions
  • History of moderate to severe clinically diagnosed mental illness
Show all 11Show fewer
  • Self-reported history of hypertension or severe heart disease
  • Self-reported history of a cardiac pacemaker or defibrillator
  • Visual and/or auditory impairment
  • Patients with craniofacial anomalies
  • History of significant motion sickness or vertigo

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Indiana University School of Dentistry Department of Orthodontics and Oral Facial Genetics Grad Clinic

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

Official title: Effects of Virtual Reality Relaxation on the Anxiety Levels of Adolescents and Adults During Orthodontic Bonding: A Randomized Controlled Trial

The goal of this clinical trial is to determine the effects of virtual reality relaxation on dental anxiety levels of adolescents and adults during an orthodontic bonding procedure.

The specific aim is to compare changes in the anxiety levels based on 1) psychological outcomes and 2) physiological outcomes between patients who experienced (virtual reality relaxation) VRR intervention during the orthodontic bonding procedure and those in the control group who did not receive the intervention

After provding written consent, subjects will be randomized to either the virtual reality device usage during their bonding procedure or no virtual reality device. They will have vital signs taken/anxiety level measured and answer a questionnaire before and after the device/no device usage (30 minutes).

Read the detailed description

On the day of the bonding procedure, informed consent will be obtained from participants and parents/guardians who were not present during the treatment plan presentation appointment. Pre-operative data will be collected, prior to the start of orthodontic treatment. Once the patient is seated, a timer will be set for 5 minutes to allow the patient to recover and get settled in before measurements are taken. After this 5-minute period, the following measurements will be collected: (1) Vitals will be recorded with the patient seated in the upright position, including maximal blood pressure (BP) using Omron 3 series upper arm blood pressure monitor with cuff on the participant's right bicep, and heart rate (HR) and oxygen saturation (SpO2) using Masimo MightySat fingertip pulse oximeter on the right ring finger; (2) The patient's state anxiety will be evaluated through the completion of the five-item state form of Spielberger's State-Trait Anxiety Inventory (STAIS-5); and (3) The patient's current anxiety level will be assessed by completing the Visual Analog Scale for anxiety (VAS-A).

The provider will review with the experimental group participants the purpose of VR and explain in a calm and soothing tone that using VR during dental procedures has been found to relax patients and to reduce their blood pressure and heart rate while also at times increasing oxygen levels. For patients in the experimental group, they will be told they will be immersed in VR for a maximum of 30 minutes. During this time period, one arch, either maxillary or mandibular, will be bonded.

Following the general explanation about the use of VR within a dental procedure, a written list with corresponding visual representation of the available virtual environments (VE) from Nature Treks will be provided (e.g. Orange Sunset, White Winter, Red Savanna). Patients will be requested to choose their preferred VE to experience during the procedure. The investigator will launch the Nature Treks application, hand the headset to the patient to put on, and assist them in adjusting the straps for a comfortable fit. A brief window of approximately 30-60 seconds will be given for them to acclimate to the virtual surroundings and to also confirm the patient's desire to proceed. During this short period, patients will be offered the choice to alter the setting or remain in it for the designated 30-minute duration. The environment selected by patients will be recorded and stored in RedCap. Participants in the control group will not be provided with the VR headset during the procedure and will have full visibility of the clinic area.

Once all relevant questions are answered, the patient will be reclined in the dental chair. The 30-minute timer will start when the orthodontic resident initiates the orthodontic bonding procedure by placing the cheek retractor for isolation.

Post-operative data will be collected 30 minutes after the start of the procedure for both groups. At the 30-minute mark, the procedure will be paused, regardless of whether the entire arch has been bonded, and all correctly positioned brackets will be light-cured to allow for the removal of isolation. The patient will then be positioned upright, and the VR headset will be removed from the experimental group. T1 data will be collected immediately, including the (1) BP, HR, and SpO2, (2) the STAIS-5 completed form, and (3) the VAS-A completed form.

Conditions
Anxiety
Being tested
virtual reality relaxation headset
Keywords
dental anxiety, orthodontic anxiety, virtual reality
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • virtual reality relaxation headsetDevice

    Also called no intervention

    No headset will be used

Study groups in NCT06804967
Study groupRoleWhat they receive
Virtual Reality Relaxation HeadsetExperimentalThe experimental group will use Virtual Reality Relaxation (VRR) during the procedure. Meta Quest 3 is a virtual reality headset featuring an adjustable, pre-installed Standard Facial Interface. It comes with two Touch Plus Controllers with wrist straps. However, to prevent gamification and interaction, hand controllers will not be provided to participants to maintain uniformity in the virtual reality experience. Participants will be restricted from engaging in active movement or interacting with the software. The headset is lightweight, weighing just over one pound, and includes a soft, adjustable strap designed to fit various head shapes and hairstyles for added comfort. It also features built-in stereo speakers with 3D spatial audio for an immersive experience. Patients will receive brief instruction on how to comfortably position and adjust the headset as well as adjust the volume.
Receives: Device: virtual reality relaxation headset
No interventionNo interventionSubjects in this group will not use the headset or any other form of intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. State and Trait Anxiety Inventory (STAI-6)

    State anxiety targets how a person feels at a specific moment while trait anxiety examines how a person usually feels. Both forms consist of anxiety-present items such as "I feel secure", and anxiety absent items, such as "I feel tense." Lower scores indicate for the purposes of this study, we will only administer the state anxiety questionnaire to determine the change in patients' anxiety levels in the dental setting.

    Measured: Baseline (Before bonding procedure) and 30 minutes.

  2. Visual analog scale for anxiety (VAS-A)

    The scale consists of a horizontal line with 'no anxiety' indicated on the left and 'worst possible anxiety' on the right. Subjects will be asked to mark (X) on the scale that best describes how they are feeling at the current moment. 0 represents not anxious at all and 10 represents extremely anxious.

    Measured: Baseline (Before bonding procedure) and 30 minutes.

Secondary outcomes (3)
  1. Blood pressure (BP)

    Blood pressure (BP) of the subjects will be measured and collected using a Omron 3 series upper arm blood pressure monitor. This physiological metric will serve as a secondary outcome measure of anxiety and will be used to provide comparative data alongside the self-reported assessments.

    Measured: Baseline (Before bonding procedure) and 30 minutes.

  2. Heart Rate (HR)

    Heart Rate (HR) of the subjects will be measured and collected using a Omron 3 series upper arm blood pressure monitor. This physiological metric will serve as a secondary outcome measure of anxiety and will be used to provide comparative data alongside the self-reported assessments.

    Measured: Baseline (Before bonding procedure) and 30 minutes.

  3. Oxygen Saturation Level (SpO2)

    Oxygen Saturation Level (SpO2) of the subjects will be measured and collected using a a Masimo MightySat fingertip pulse oximeter. This physiological metric will serve as a secondary outcome measure of anxiety and will be used to provide comparative data alongside the self-reported assessments.

    Measured: Baseline (Before bonding procedure) and 30 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2025
  2. Study start21 Jan 2025
  3. Primary completion1 Jul 2025
  4. Study completion4 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06804967
Sponsor's protocol ID
25009
Status last verified
Apr 2026
First submitted
13 Jan 2025
Last updated
7 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Individual participant data (IPD) will not be shared due to the HIPAA regulations.

Questions about this trial

What is this clinical trial studying?

A study testing virtual reality relaxation headset in people with Anxiety, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

State and Trait Anxiety Inventory (STAI-6) (time frame: Baseline (Before bonding procedure) and 30 minutes.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in